Shared Biomarkers Between Female Diastolic Heart Failure and Pre-eclampsia: a Systematic Review and Meta-analysis

Overview

Journal ESC Heart Fail

Date 2017 Apr 29

PMID 28451444

Citations 16

Authors

Lisa J Alma

Anouk Bokslag

Angela H E M Maas

Arie Franx

Walter J Paulus

Christianne J M de Groot

Affiliations

Soon will be listed here.

Abstract

Evidence accumulates for associations between hypertensive pregnancy disorders and increased cardiovascular risk later. The main goal of this study was to explore shared biomarkers representing common pathogenic pathways between heart failure with preserved ejection fraction (HFpEF) and pre-eclampsia where these biomarkers might be potentially eligible for cardiovascular risk stratification in women after hypertensive pregnancy disorders. We sought for blood markers in women with diastolic dysfunction in a first literature search, and through a second search, we investigated whether these same biochemical markers were present in pre-eclampsia.This systematic review and meta-analysis presents two subsequent systematic searches in PubMed and EMBASE. Search I yielded 3014 studies on biomarkers discriminating women with HFpEF from female controls, of which 13 studies on 11 biochemical markers were included. Cases had HFpEF, and controls had no heart failure. The second search was for studies discriminating women with pre-eclampsia from women with non-hypertensive pregnancies with at least one of the biomarkers found in Search I. Search II yielded 1869 studies, of which 51 studies on seven biomarkers were included in meta-analyses and 79 studies on 12 biomarkers in systematic review.Eleven biological markers differentiated women with diastolic dysfunction from controls, of which the following 10 markers differentiated women with pre-eclampsia from controls as well: C-reactive protein, HDL, insulin, fatty acid-binding protein 4, brain natriuretic peptide, N terminal pro brain natriuretic peptide, adrenomedullin, mid-region pro adrenomedullin, cardiac troponin I, and cancer antigen 125.Our study supports the hypothesis that HFpEF in women shares a common pathogenic background with pre-eclampsia. The biomarkers representing inflammatory state, disturbances in myocardial function/structure, and unfavourable lipid metabolism may possibly be eligible for future prognostic tools.

Citing Articles

Gender-specific genetic and epigenetic signatures in cardiovascular disease.

Bridges J, Ramirez-Guerrero J, Rosa-Garrido M Front Cardiovasc Med. 2024; 11:1355980.

PMID: 38529333 PMC: 10962446. DOI: 10.3389/fcvm.2024.1355980.

Risk Prediction Model of Early-Onset Preeclampsia Based on Risk Factors and Routine Laboratory Indicators.

Xue Y, Yang N, Gu X, Wang Y, Zhang H, Jia K Life (Basel). 2023; 13(8).

PMID: 37629504 PMC: 10455518. DOI: 10.3390/life13081648.

Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.

Rabkin S EXCLI J. 2022; 21:487-518.

PMID: 35391918 PMC: 8983850. DOI: 10.17179/excli2021-4572.

Pregnancy Complications Can Foreshadow Future Disease-Long-Term Outcomes of a Complicated Pregnancy.

Panaitescu A, Popescu M, Ciobanu A, Gica N, Cimpoca-Raptis B Medicina (Kaunas). 2021; 57(12).

PMID: 34946265 PMC: 8704070. DOI: 10.3390/medicina57121320.

Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative.

Hansen A, Sondergaard M, Hlatky M, Vittinghof E, Nah G, Stefanick M JAMA Netw Open. 2021; 4(12):e2138071.

PMID: 34882182 PMC: 8662370. DOI: 10.1001/jamanetworkopen.2021.38071.

References

Szabo G, Molvarec A, Nagy B, Rigo Jr J . Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia. Clin Chem Lab Med. 2013; 52(2):281-8. DOI: 10.1515/cclm-2013-0307. View

Duvan C, Simavli S, Aktepe Keskin E, Onaran Y, Turhan N, Koca C . Is the level of maternal serum prohepcidin associated with preeclampsia?. Hypertens Pregnancy. 2014; 34(2):145-52. DOI: 10.3109/10641955.2014.988350. View

Visser S, Hermes W, Ket J, Otten R, van Pampus M, Bloemenkamp K . Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders. Am J Obstet Gynecol. 2014; 211(4):373.e1-9. DOI: 10.1016/j.ajog.2014.03.032. View

Ziaei S, Jahanian S, Kazemnejad A . Lipid concentration in small for gestational age (SGA)pregnancies and hypertensive disorders. Pregnancy Hypertens. 2015; 2(2):164-7. DOI: 10.1016/j.preghy.2012.01.007. View

Mosca L, Benjamin E, Berra K, Bezanson J, Dolor R, Lloyd-Jones D . Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011; 57(12):1404-23. PMC: 3124072. DOI: 10.1016/j.jacc.2011.02.005. View

Miralles C, Orea M, Espana P, Provencio M, Sanchez A, Cantos B . Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol. 2003; 10(2):150-4. DOI: 10.1245/aso.2003.05.015. View

. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002; 77(1):67-75. View

Behboudi Gandevani S, Banaem L, Mohamadi B, Moghadam N, Asghari M . Association of high-sensitivity C-reactive protein serum levels in early pregnancy with the severity of preeclampsia and fetal birth weight. J Perinat Med. 2012; 40(6):601-5. DOI: 10.1515/jpm-2011-0190. View

George J, Rapsomaniki E, Pujades-Rodriguez M, Shah A, Denaxas S, Herrett E . How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1,937,360 People. Circulation. 2015; 132(14):1320-8. PMC: 4590518. DOI: 10.1161/CIRCULATIONAHA.114.013797. View

10.

Fleming S, OGorman T, Finn J, Grimes H, Daly K, Morrison J . Cardiac troponin I in pre-eclampsia and gestational hypertension. BJOG. 2000; 107(11):1417-20. DOI: 10.1111/j.1471-0528.2000.tb11658.x. View

11.

Hwang H, Kwon J, Kim M, Park Y, Kim Y . Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet. 2007; 98(2):105-9. DOI: 10.1016/j.ijgo.2007.03.050. View

12.

Kaaja R, Moore M, Yandle T, Ylikorkala O, Frampton C, Nicholls M . Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy. 1999; 18(2):173-87. DOI: 10.3109/10641959909023077. View

13.

Tjoa M, van Vugt J, Go A, Blankenstein M, Oudejans C, van Wijk I . Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003; 59(1):29-37. DOI: 10.1016/s0165-0378(02)00085-2. View

14.

Swellam M, Samy N, Wahab S, Ibrahim M . Emerging role of endothelial and inflammatory markers in preeclampsia. Dis Markers. 2009; 26(3):127-33. PMC: 3833325. DOI: 10.3233/DMA-2009-0622. View

15.

Mori T, Shinohara K, Wakatsuki A, Watanabe K, Fujimaki A . Adipocytokines and endothelial function in preeclamptic women. Hypertens Res. 2010; 33(3):250-4. DOI: 10.1038/hr.2009.222. View

16.

Van Veldhuisen D, Linssen G, Jaarsma T, van Gilst W, Hoes A, Tijssen J . B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013; 61(14):1498-506. DOI: 10.1016/j.jacc.2012.12.044. View

17.

Gohil J, Patel P, Gupta P . Estimation of lipid profile in subjects of preeclampsia. J Obstet Gynaecol India. 2012; 61(4):399-403. PMC: 3295880. DOI: 10.1007/s13224-011-0057-0. View

18.

Hata T, Miyazaki K, Matsui K . Decreased circulating adrenomedullin in pre-eclampsia. Lancet. 1997; 350(9091):1600. DOI: 10.1016/S0140-6736(05)64016-0. View

19.

Braekke K, Holthe M, Harsem N, Fagerhol M, Staff A . Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol. 2005; 193(1):227-33. DOI: 10.1016/j.ajog.2004.11.055. View

20.

Nieminen M, Harjola V, Hochadel M, Drexler H, Komajda M, Brutsaert D . Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail. 2008; 10(2):140-8. DOI: 10.1016/j.ejheart.2007.12.012. View